One key incentive for Pfizer paying $11 billion for Array BioPharma was the positive early readouts from its triplet therapy for colorectal cancer. Now, the biotech has shown exactly how attractive ...
One seismometer is often not enough to reliably detect earthquakes or human activity such as underground nuclear tests.
The news that Array BioPharma’s clinical trial of its triplet therapy for colon cancer extended lives in a trial of patients with the BRAF mutation sent the company’s shares up 23% on Tuesday—a run ...
One way of viewing efforts by storage suppliers to move into data management over the past couple of years is that storage technology is emerging from the backroom and wants to be at the centre of ...
Navigating the world of Excel can sometimes feel like trying to solve a puzzle with missing pieces. If you’ve ever found yourself wrestling with the XLOOKUP function, only to be met with a chaotic ...
A technical paper titled “Massive Data-Centric Parallelism in the Chiplet Era” was published by researchers at Princeton University. “Traditionally, massively parallel applications are executed on ...
We’re just starting to tap the potential of what AI can do. But amid all the breakthroughs, one thing is fundamental: AI is only as good as the data it was trained on. Unlike people, who can draw on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results